STACEY MOLINERE: Open Payments
NPI 1992743892 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 51 payments from 12 companies in 2025. Trend: 2023 $803 · 2024 $1,401 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $286 |
| ABBVIE INC. | 12 | $215 |
| Otsuka America Pharmaceutical, Inc. | 10 | $181 |
| Janssen Pharmaceuticals, Inc | 3 | $94 |
| Indivior Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Alkermes, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Sage Therapeutics, LLC | 1 | $15 |
Products named: CAPLYTA, VRAYLAR, SUBLOCADE, INVEGA SUSTENNA, FANAPT, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
